PROTOPORPHYRIA

Clinical trials for PROTOPORPHYRIA explained in plain language.

Never miss a new study

Get alerted when new PROTOPORPHYRIA trials appear

Sign up with your email to follow new studies for PROTOPORPHYRIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Withdrawn trial sought to protect livers in rare Light-Sensitivity disease

Disease control Terminated

This study aimed to test the safety of an investigational drug called bitopertin in adults with a rare disorder called protoporphyria, which can cause severe pain from sunlight and sometimes damage the liver. The goal was to see if daily bitopertin could lower harmful substances …

Matched conditions: PROTOPORPHYRIA

Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

PROTOPORPHYRIA

Get alerted when new PROTOPORPHYRIA trials appear

Withdrawn trial sought to protect livers in rare Light-Sensitivity disease